Survival is higher after repeat lung metastasectomy than after a first metastasectomy: Too good to be true?
نویسندگان
چکیده
منابع مشابه
Survival after Liver Metastasectomy in Colorectal Cancer Cases in Turkey
Colorectal cancer (CRC) is the third most common diagnosed malignancy in the world and is the second leading cause of cancer death in developed countries (Rebecca et al., 2012). Colorectal cancer is the fourth leading cause of cancer and cancer related deaths among both men and women in Turkey. Distant metastasis is the main cause of death in CRC patients. The liver is the most frequent (approx...
متن کامل5-year survival after multiple repeat metastasectomy for pulmonary artery angiosarcoma.
Primary pulmonary artery angiosarcomas are rare malignant tumors with few reported survivors. We report a case of a 39-year-old woman without evidence of disease 5 years after initial diagnosis and after multiple metastasectomies and pulmonary artery tumor endarterectomy.
متن کاملLCZ696: too good to be true?
This issue of the European Heart Journal contains a major statement by the PARADIGM-HF Investigators, who present an ‘putative placebo’ analysis for LCZ696, a new medicine that yielded a remarkable reduction in total mortality and heart failure events in patients with significant heart failure with reduced ejection fraction (HF-REF). (NB: I serve as a consultant on Novartis’s cardiovascular–met...
متن کاملSurvival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era
BACKGROUND A clear survival benefit has been reported for lung metastasectomy for colorectal cancer, and several clinicopathological prognostic factors have been proposed in the past. However, clinical advances, such as chemotherapy and radiographic imaging, should have improved patient outcome and may have altered prognosticators. This study aimed to assess patient survival and determine progn...
متن کاملSurvival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Background: Cisplatin-based combination chemotherapy is standard treatment for metastatic urothelial carcinoma; however, the vast majority of patients experience disease progression. As systemic therapy alone is rarely curative for the treatment of metastatic urothelial cancer, not only are new therapies needed but also refinement of general treatment principles. Herein, we conducted a systemat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Thoracic and Cardiovascular Surgery
سال: 2015
ISSN: 0022-5223
DOI: 10.1016/j.jtcvs.2015.01.067